Design and Analysis of Group Sequential Clinical Trials with Multiple Primary Endpoints (Q3435673): Difference between revisions
From MaRDI portal
Set profile property. |
Created claim: Wikidata QID (P12): Q44806501, #quickstatements; #temporary_batch_1722035971323 |
||
| (One intermediate revision by one other user not shown) | |||
| Property / cites work | |||
| Property / cites work: Q3999494 / rank | |||
Normal rank | |||
| Property / cites work | |||
| Property / cites work: Q3747485 / rank | |||
Normal rank | |||
| Property / cites work | |||
| Property / cites work: Group sequential designs for one-sided and two-sided hypothesis testing with provision for early stopping in favor of the null hypothesis / rank | |||
Normal rank | |||
| Property / cites work | |||
| Property / cites work: Repeated Significance Testing for a General Class of Statistics Used in Censored Survival Analysis / rank | |||
Normal rank | |||
| Property / Wikidata QID | |||
| Property / Wikidata QID: Q44806501 / rank | |||
Normal rank | |||
Latest revision as of 00:28, 27 July 2024
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Design and Analysis of Group Sequential Clinical Trials with Multiple Primary Endpoints |
scientific article |
Statements
Design and Analysis of Group Sequential Clinical Trials with Multiple Primary Endpoints (English)
0 references
7 May 2007
0 references
alpha-spending function
0 references
beta-spending function
0 references
multivariate outcomes
0 references
sample size
0 references
time-to-event data
0 references
